Does ABROCITINIB Cause Deep vein thrombosis? 15 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Deep vein thrombosis have been filed in association with ABROCITINIB (CIBINQO). This represents 0.5% of all adverse event reports for ABROCITINIB.
15
Reports of Deep vein thrombosis with ABROCITINIB
0.5%
of all ABROCITINIB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Deep vein thrombosis From ABROCITINIB?
Of the 15 reports, 7 (46.7%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Deep vein thrombosis Listed in the Official Label?
Yes, Deep vein thrombosis is listed as a known adverse reaction in the official FDA drug label for ABROCITINIB.
What Other Side Effects Does ABROCITINIB Cause?
Drug ineffective (398)
Condition aggravated (316)
Off label use (269)
Therapeutic product effect incomplete (186)
Pruritus (171)
Rash (134)
Nausea (130)
Dermatitis atopic (110)
Headache (85)
Acne (73)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which ABROCITINIB Alternatives Have Lower Deep vein thrombosis Risk?
ABROCITINIB vs ACALABRUTINIB
ABROCITINIB vs ACAMPROSATE
ABROCITINIB vs ACARBOSE
ABROCITINIB vs ACCUTANE
ABROCITINIB vs ACEBUTOLOL